title: In reply to Putnam.
authors.affiliation: Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
authors.forename: Ryan
authors.initials: R
authors.lastname: Hickey
authors.affiliation: Division of Medical Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
authors.forename: Mary
authors.initials: M
authors.lastname: Mulcahy
authors.affiliation: Division of Interventional Oncology, Department of Radiology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.
authors.forename: Riad
authors.initials: R
authors.lastname: Salem
mesh_terms: D059248:Chemoradiotherapy / Q000379:methods*; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D015019:Yttrium / Q000627:therapeutic use*
chemical_list: D011838:Radiation-Sensitizing Agents; D003841:Deoxycytidine; D015019:Yttrium; D005472:Fluorouracil